Schuichi Koizumi

Schuichi Koizumi

Department of Neuropharmacology, University of Yamanashi

Affiliated withUniversity of Yamanashi

Research Area

Biography

Dr Koizumi received his PhD at Kyushu University majored in Neuropharmacology, and then did posdoc in Health Science foundation in Japan (Prof Inoue), and in Cambridge University in UK (Prof Mike Berridge). He got a Researcher position in 1999 in National Institute of Health Sciences in Japan, and then got a Professor position in 2007 at Faculty of Medicine, Univ Yamanashi in Japan.

Dr Koizumi is interested in physiology and pathophysiology of glia-neuron interaction in relation to several brain diseases. In 2021, He established Yamanashi GLIA Centre in the university, and is a director of the Centre. He is also interested in ATP purinertic signalling, a pivotal mediator between glia and neurons. The current special interest is to clarify mechanisms underlying synapse formation and elimination mediated by astrocytes/microglia in many of pathophysiological conditions.

JoVE Journal Publications

ArticleTotal : 2
Year
<em>In Vivo</em> Wide-Field and Two-Photon Calcium Imaging from a Mouse Using a Large Cranial Window
Publication title

Cited by 9

2022
2022

Other Publications

Article
Year
UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis.

Nature| PubMed ID: 17410128

2007
2007
2007
[Regulation of brain function mediated by glial ATP sensors].

Seikagaku. The Journal of Japanese Biochemical Society| PubMed ID: 19260453

2009
2009
2009
2009
2010
2010
Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase.

The Journal of pharmacology and experimental therapeutics| PubMed ID: 21765041

2011
2011
2012
Cell-autonomous enhancement of glutamate-uptake by female astrocytes.

Cellular and molecular neurobiology| PubMed ID: 22450870

2012
2013
Purinergic signaling promotes proliferation of adult mouse subventricular zone cells.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 22764232

2012
2013
2013
2013
Microglia release ATP by exocytosis.

Glia| PubMed ID: 23832620

2013
2013
Mechanism underlying ATP release in human epidermal keratinocytes.

The Journal of investigative dermatology| PubMed ID: 24292772

2014
2014
2014
Expression of astrocyte-related receptors in cortical dysplasia with intractable epilepsy.

Journal of neuropathology and experimental neurology| PubMed ID: 25003238

2014
TRPV4 regulates the integrity of the blood-cerebrospinal fluid barrier and modulates transepithelial protein transport.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology| PubMed ID: 25681460

2015
2015
Astrocyte-mediated ischemic tolerance.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 25740510

2015
2016
2016
2016
2017
2016
2016
2017
2017
2017
2017
2017
2017
2017
2017
2017
2017
2018
2017
2017
Astrocytes and ischemic tolerance.

Neuroscience research| PubMed ID: 29225139

2018
Astrocytes as therapeutic targets in brain diseases.

Neuroscience research| PubMed ID: 29289274

2018
Role of Purinergic Receptor P2Y1 in Spatiotemporal Ca Dynamics in Astrocytes.

The Journal of neuroscience : the official journal of the Society for Neuroscience| PubMed ID: 29305530

2018
2018
2018
2018
2018
2018
Neuroprotective effects of microglial P2Y receptors against ischemic neuronal injury.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism| PubMed ID: 30334687

2019
2018
2018
[Epileptogenesis mediated by glial cells].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica| PubMed ID: 30531096

2018
Aberrant Calcium Signals in Reactive Astrocytes: A Key Process in Neurological Disorders.

International journal of molecular sciences| PubMed ID: 30823575

2019
Hyaluronan synthesis supports glutamate transporter activity.

Journal of neurochemistry| PubMed ID: 31188471

2019
2019
2019
2019
2019
2019
[Pathogenic roles of retinal glia in glaucoma].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica| PubMed ID: 32115484

2020
2020
2021
Potential roles of astrocytes and Müller cells in the pathogenesis of glaucoma.

Journal of pharmacological sciences| PubMed ID: 33602506

2021
2021
2021
2021
2021
2021
Loss of P2Y receptors triggers glaucoma-like pathology in mice.

British journal of pharmacology| PubMed ID: 34309010

2021
2021
2021
Goshajinkigan attenuates paclitaxel-induced neuropathic pain via cortical astrocytes.

Pharmacology research & perspectives| PubMed ID: 34676996

2021
Glial pharmacology in Asia & Beyond.

Pharmacology research & perspectives| PubMed ID: 34676997

2021
Abnormal Ca Signals in Reactive Astrocytes as a Common Cause of Brain Diseases.

International journal of molecular sciences| PubMed ID: 35008573

2021
The Mlc1 Promoter Directs Müller Cell-specific Gene Expression in the Retina.

Translational vision science & technology| PubMed ID: 35040915

2022
Glial Purinergic Signals and Psychiatric Disorders.

Frontiers in cellular neuroscience| PubMed ID: 35069121

2021
2022
Effects of fatty acid metabolites on nocturia.

Scientific reports| PubMed ID: 35197540

2022
2022
P2X7 Receptors in Astrocytes: A Switch for Ischemic Tolerance.

Molecules (Basel, Switzerland)| PubMed ID: 35744780

2022
2022
Ischemic Tolerance Induced by Glial Cells.

Neurochemical research| PubMed ID: 35920970

2022